Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02518997 · ClinicalTrials.gov registry record · NA

Effects of Reading to Preterm Infants on Baby and Parents' Well Being

A NA study, sponsored by Georgetown University.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT02518997: Completed NA study, sponsored by Georgetown University.

NCT02518997 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02518997, a NA study, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

Reading to children is believed to be beneficial to cognitive and mental development.This study will examine the response of premature Neonatal Intensive Care Unit (NICU) infants to bedside reading by measuring changes in heart rate, blood pressure, breathing and oxygen levels. The investigators will follow rates of common preterm health issues while in the hospital and time to hospital discharge. Effects of bedside reading on parental stress and infant bonding will be measured and compared to usual rates of these indicators to determine if reading to babies reduces stress and enhances bonding.

Primary Outcome

Percent of measured oxygen saturations recorded as less than 85%

Interventions

  • OTHER Parental Reading Aloud

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2014-10
Est. Completion 2018-03
Phase NA
Georgetown University

227 total trials

What the finished NCT02518997 record still lists

NCT02518997 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Parental Reading Aloud is the first listed.

NCT02518997 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02518997 about?

NCT02518997 is a clinical study titled "Effects of Reading to Preterm Infants on Baby and Parents' Well Being". Reading to children is believed to be beneficial to cognitive and mental development.This study will examine the response of premature Neonatal Intensive Care Unit (NICU) infants to bedside reading by measuring changes in heart rate, blood pressure, breathing and oxygen levels. The investigators wil...

What is the current status of trial NCT02518997?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-10. Estimated completion is 2018-03.

What interventions are being tested in trial NCT02518997?

The interventions under investigation include: Parental Reading Aloud (OTHER).

Who is sponsoring clinical trial NCT02518997?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02518997's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02518997, the US trial registry maintained by the National Library of Medicine. NCT02518997 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.